Apetamin: Use of This Illegal Weight-Gain Product Can Bring Tragic Results

TUESDAY, May 2, 2023 (HealthDay News) -- U.S. regulators are urging Americans to avoid Apetamin, an illegal drug used for weight gain and figure enhancement. The substance, typically sold as a syrup, is manufactured overseas, is illegally imported, and is not approved by the U.S. Food and Drug Administration.
Apetamin contains the potent antihistamine cyproheptadine, which requires a physician's prescription in the United States. American consumers may find Apetamin online, on social media, or in some retail stores, but they should not use it, the FDA warned in an agency news release.
Among its dangerous side effects are potential overdose, sedation, cognitive impairment, dizziness, low blood pressure, disorientation and confusion, hallucinations, convulsions, and decreased breath and heart rates. It may lead to coma or death, the FDA said. The substance also decreases mental alertness, which may affect a person's ability to drive a car or operate machinery.
This strong antihistamine may be dangerously strengthened when taken with alcohol and other central nervous system depressants, such as hypnotics, sedatives, tranquilizers, and anti-anxiety medications, the FDA said.
Reports to the FDA Adverse Event Reporting System revealed young adults had taken Apetamin and experienced nervous system disorders, cardiac disorders, and liver injury, the agency said.
Related Posts
EPA Awards $58 Million to Help Schools, Daycare Centers Remove Lead From Drinking Water
TUESDAY, July 25, 2023 (HealthDay News) -- The Biden administration on Monday...
Prestigious Sports Medicine Journal Retracts Articles Authored by Former Editor-in-Chief
TUESDAY, Oct. 11, 2022 (HealthDay News) -- A leading medical journal, the...
Vitamin D Could Help Extend Your Life: Study
TUESDAY, Oct. 25, 2022 (HealthDay News) -- A vitamin D deficiency puts you at...
Empresa retira el “Desafío de un solo chip” de estantes de las tiendas, después de que un adolescente fallece
VIERNES, 8 de septiembre de 2023 (Noticias HealthDay) -- El fabricante del...